Thromboelastography-based assessment of coagulation function in patients with chronic kidney disease and the risk factors of hypercoagulability.
10.12122/j.issn.1673-4254.2020.04.17
- Author:
Sixian WU
1
;
Hao YUAN
1
;
Yifeng ZHOU
2
;
Zhenyi LONG
1
;
Yameng PENG
1
;
Fang PENG
1
Author Information
1. Clinical Laboratory, First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha 410005, China.
2. Operating Room, First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha 410005, China.
- Publication Type:Journal Article
- Keywords:
chronic kidney disease;
hypercoagulability;
maximal amplitude;
risk factors;
thromboelastography
- MeSH:
Blood Coagulation;
Humans;
Renal Insufficiency, Chronic;
Risk Factors;
Thrombelastography;
Thrombophilia
- From:
Journal of Southern Medical University
2020;40(4):556-561
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the changes in the coagulation profiles of patients with chronic kidney disease (CKD) using thromboelastography (TEG) and identify the risk factors of hypercoagulation in CKD patients.
METHODS:A total of 128 patients with CKD admitted in Hunan Provincial People's Hospital between August, 2018 and May, 2019 were recruited. The results of conventional coagulation test and TEG were compared between patients with CKD and 21 healthy control adults. The patients with CKD were divided into hypercoagulation group with a maximum amplitude (MA) > 68 mm (=66) and non-hypercoagulation group (MA≤68 mm, =62). The laboratory indicators were compared between the groups, and the factors affecting the hypercoagulable state in patients with CKD were analyzed.
RESULTS:The levels of fibrinogen and D-Dimer increased significantly in patients with CKD at different stages as compared with the control subjects ( < 0.05). In the patients with CKD, the reaction time and K time decreased while MA, α-angle and coagulation index increased significantly in patients in stage 3-4 and those in stage 5 either with or without hemodialysis compared with the control group ( < 0.05). The estimated glomerular filtration rate (eGFR), percentage of patients with diabetes mellitus, history of stroke, percentage of neutrophils, neutrophil-lymphocyte ratio, red blood cell count, hemoglobin levels, platelet count, serum creatinine, serum cystatin-C, serum albumin, and lipoprotein (a) all differed significantly between hypercoagulation group and non-hypercoagulation group ( < 0.05). The eGFR, platelet count and hemoglobin levels were identified as independent factors affecting hypercoagulability in patients with CKD ( < 0.05).
CONCLUSIONS:s The hypercoagulable state of patients with CKD worsens gradually with the disease progression, and eGFR, platelet count and hemoglobin levels are all risk factors for the hypercoagulable state in patients with CKD.
